top of page
2.jpg

RESEARCH NOTICE & LEGAL DISCLAIMER

FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.

  • Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.

  • Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.

  • Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.

Fitness

CJC+IPAMORELIN
20MG

PRODUCT NAME (2).png

The combination of CJC-1295 (No DAC) and Ipamorelin is widely regarded in research as the gold standard for naturally enhancing Growth Hormone (GH) levels. By blending these two peptides, researchers aim to create a "synergistic" effect—meaning the two compounds together produce a much stronger result than either could achieve on its own.

How it Works

This blend targets the pituitary gland using two different pathways to maximize the release of Growth Hormone:

  • CJC-1295 (No DAC): Acts as a GHRH (Growth Hormone Releasing Hormone) analog. It acts like a "constant signal," telling the pituitary gland to increase the production and steady release of growth hormone.

  • Ipamorelin: Acts as a GH Secretagogue (GHS) by mimicking the hormone ghrelin. It acts as a "trigger," causing a specific, large pulse of growth hormone to be released.

  • The Synergy: Ipamorelin provides the sharp "spike" in GH, while CJC-1295 ensures that the spike is larger and the background levels remain optimized. This mimics the body's natural pulsatile rhythm more closely than synthetic HGH.

Research Findings

  • Selective Action: Unlike older peptides (like GHRP-2 or GHRP-6), Ipamorelin is highly selective. Research shows it stimulates GH without significantly raising cortisol (the stress hormone) or prolactin, reducing the risk of unwanted side effects.

  • Body Composition: Studies suggest this combination is highly effective at promoting "lipolysis" (fat burning) while simultaneously supporting the development of lean muscle tissue.

  • Recovery and Sleep: GH is primarily released during deep sleep. Researchers have noted that this blend can improve "slow-wave" sleep quality, leading to faster physical recovery and improved mental clarity.

  • Anti-Aging and Skin: By increasing IGF-1 (a growth factor triggered by GH), research indicates potential improvements in skin elasticity, bone density, and cellular repair.

Reconstitution & Dosing Protocol

To prepare a 10mg blend vial (which contains 5mg of CJC-1295 No DAC and 5mg of Ipamorelin), follow these instructions for a precise research protocol.

1. Preparation (Reconstitution)

  • Gently inject 3ml of Bacteriostatic Water into your 10mg blend vial.

  • Aim the water at the inside glass wall of the vial so it trickles down slowly; do not spray it directly onto the powder.

  • Do not shake the vial. Gently swirl or roll it between your hands until the liquid is clear and the powder is fully dissolved.

  • Crucial: Once mixed, the vial must be stored in the refrigerator at all times.

2. The Daily Dosing Method (Subcutaneous Injection)

  • Frequency: Inject once per day, ideally at night before bed (on an empty stomach) to align with the body's natural GH release.

  • Administration: Use a standard U-100 insulin syringe. Inject into the fatty tissue (stomach area).

The Protocol (Gradual Titration):

  • Weeks 1 to 2 (Introductory Phase): Draw the liquid to the 3 unit mark on your insulin syringe and inject once daily. (This provides 100mcg of each peptide).

  • Weeks 3 to 4 (Adjustment Phase): Draw the liquid to the 4.5 unit mark on your insulin syringe and inject once daily. (This provides 150mcg of each peptide).

  • Weeks 5 to 6 (Mid-Cycle Phase): Draw the liquid to the 6 unit mark on your insulin syringe and inject once daily. (This provides 200mcg of each peptide).

  • Weeks 7 to 12 (Target Phase): Draw the liquid to the 9 unit mark on your insulin syringe and inject once daily. (This provides 300mcg of each peptide).

SAHPRA Disclaimer: This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). This product is not intended to diagnose, treat, cure, or prevent any disease. The information provided is for educational purposes only and should not replace professional medical advice.

RESEARCH USE ONLY

Biolabs Operating Hours

  • Monday – Friday: 9:00 AM – 4:00 PM

  • Saturday & Sunday: Closed

  • Public Holidays: Closed

BIOLABS

FOLLOW US

JOIN OUR NEWSLETTER

© 2026 by BIOLABS South Africa

bottom of page